Flat abs: Two fitness experts offer 6 secrets for toning and tightening the tummy.

  Denying you have type 2 diabetes won't make it go away. Here's how to accept your diagnosis, manage your disease, and get on with your life.

  A new inflammation-fighting drug may spell relief for people with severe gout who are unable to take currently available gout treatment because of underlying health problems.

  Facial bones shift with age, setting the stage for faces to sag, Duke University researchers report.

  The FDA has approved nonprescription Zyrtec-D, an over-the-counter allergy drug for people age 12 and older.

  Heads up, Lancelot: A traditional Chinese medicine called dragon's blood may fight ulcer bacteria and blood clots, Shanghai lab tests show.

  Combination therapy including TNF-inhibitors along with an older drug known as methotrexate (MTX) can slash the risk of heart attack in people with rheumatoid arthritis (RA).

  Botox injections may ease shoulder pain from osteoarthritis, researchers tell the American College of Rheumatology's annual meeting.

  Extraweight, metabolic syndrome, and parental diabetes make kids more likely to become diabetic adults, experts report in The Journal of Pediatrics.

  The holidays should be about making good memories, not about making things perfect. These 5 tips start you on your way to happy holidays.

  People with rheumatoid arthritis (RA) who are overweight or obese may be less likely to go into remission when they are treated with a combination of conventional disease modifying anti-rheumatic drugs (DMARDs) and steroids than their thinner counterparts, a study shows.

  Women who use oral contraceptives have an increased risk of developing cervical cancer, but the risk drops quickly once the pill is stopped.

  Baby boomer women are concerned about how to care for their aging parents, but few are planning for it, according to a survey by AARP.

  The number of bleeding ulcers and other gastrointestinal complications has increased since a class of pain drugs called Cox-2 inhibitors fell out of favor due to their increased risk of heart attack or stroke, according to a new study.